Jack Aiello | CureTalks
Jack Aiello of San Jose, California is a leading patient advocate in multiple myeloma. In January of 1995 Jack had a terrible backache. He was diagnosed with multiple myeloma through a blood test. Since that time Jack has had stem cell transplants and clinical trials that have brought him to remission, even if only for a short time. However, ultimately he had a full allogenic (donor stem cells) transplant, resulting in a long-term remission. While he has long-term side effects, Jack's spirit remains high and is very much involved with cancer advocacy organizations such as the International Myeloma Foundation, Multiple Myeloma Research Foundation, The Leukemia & Lymphoma Society (LLS) and Myeloma Crowd, all of which provide research dollars and education programs for multiple myeloma. He also served on myeloma committees which focus on developing clinical trials, offering his patient perspective to the National Cancer Institute, SWOG Cancer Research Institute, BMT Clinical Trials Network, and Stanford’s Scientific Review Committee.
Related Talks
Myeloma Relapse with Dr. Rodger Tiedemann
On this show hematologist and scientist Dr. Rodger Tiedemann of Ontario Cancer Institute talks about his research on myeloma relapse and its relation…
High Risk Multiple Myeloma Survival w/ Dr. Rafael Fonseca of Mayo Clinic
What does high-risk means in a patient who is diagnosed with multiple myeloma? What are the markers that determine the most common sub-category…
Myeloma ASH 2013 Review
Tune in to get interesting myeloma updates - 2013 ASH conference, from Myeloma Support Group leaders and myeloma advocates, Gary Petersen, Pat Killingsworth,…
Dana Farber’s Dr. Richardson on Transplants in Myeloma
To Transplant or Not To Transplant: Hear it from world renowned myeloma expert, Dr. Paul Richardson of Harvard's Dana Farber Cancer Center.
Discussing Myeloma Clinical Trials with Dr.Chari from Mount Sinai
Dr. Ajai-Chari from Mount Sinai Hospital, New York, a renowned myeloma expert, discusses Clinical Trials related to myeloma.